Answer
It is unknown whether idarucizumab or its metabolites are excreted in human breast milk.
Sources for this answer
- Praxbind 2.5 g/50 mL solution for injection/infusionBoehringer Ingelheim Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 12Document updated
Sources checked